OIG ramps up Medicaid fraud efforts
Executive Summary
The HHS Office of the Inspector General will increase its presence in the Medicaid fraud arena, Inspector Thomas Sowinski said at a RAPS conference held in Denver May 1-2. Congress recently authorized the agency a "decent" sum of money to hire approximately 30 more agents to be specifically assigned to Medicaid related cases, he said, noting that previously, "we were very limited in the drug cases that we would work." He also said that Part D may increase Medicare fraud investigations. "You are going to see cases that could deal with the formularies for the drug plans, if drug companies or others are enticing them to include their drug on a formulary for another reason than just an effective drug, that might be something we are going to investigate"...
You may also be interested in...
Xbrane Assembles The Troops As FDA Says No To Lucentis Biosimilar
Xbrane Biopharma was riding the crest of a wave with the EU launch of its biosimilar to Lucentis, following years of toil and investment. However, plans to roll out the product in the US will have to be pushed back – likely – into the middle of 2025, following a US FDA complete response letter.
UK MHRA Updates Assistive Tech And Borderline Regulations
Device classification themes were uppermost in April for the UK regulator, which issued key guidance in two areas prone to complexities. It also contributed to the MedTech Directorate’s one-year progress report.
Fujifilm Demonstrates Health Specialism With European HealthTech Spinout
From X-ray film in 1936 to the world’s first digital X-ray system in 1983, Fujifilm has a long heritage in medical diagnostics.